BiotechTube
Flomics

Flomics

Barcelona, Spain· Est.
flomics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.3M

Overview

Founded in 2015, Flomics is a private, pre-revenue diagnostics company pioneering an RNA-based liquid biopsy platform. Its technology combines optimized NGS protocols for cfRNA with proprietary bioinformatics and AI to detect cancer and other complex diseases from a blood sample. The company also offers end-to-end genomics services for research partners while advancing its own multi-cancer screening test toward clinical validation.

Oncology

Technology Platform

Next-generation liquid biopsy platform combining optimized NGS of cell-free RNA (cfRNA) from blood with proprietary machine learning algorithms to detect disease-specific expression signatures.

Funding History

2
Total raised:$2.3M
Grant$500K
Seed$1.8M

Opportunities

The global multi-cancer early detection market is a multi-billion dollar opportunity driven by the unmet need for non-invasive, population-scale screening.
Flomics' RNA-centric approach could offer superior biological insight for detecting certain cancers earlier than DNA-based methods, providing a key differentiation in a competitive landscape.

Risk Factors

Key risks include the significant technical and clinical validation hurdles for a novel RNA-based MCED test, a complex and costly regulatory pathway, and intense competition from well-funded companies with alternative technological approaches (e.g., ctDNA methylation).
Securing sufficient funding for large-scale trials is also a critical challenge.

Competitive Landscape

Flomics competes in the crowded liquid biopsy and MCED space against companies like Grail (ctDNA methylation), Freenome (multi-omics), and Exact Sciences. Its differentiation is its focus on cell-free RNA and expression patterns, which may capture different biological signals than DNA-based methods, but it must prove clinical advantage against established front-runners.

More companies in Diagnostics & Precision Medicine →More companies in Spain →